The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Microtubule-targeting agents and their impact on cancer treatment
Open accessAbstract
Microtubule-targeting agents (MTAs) constitute a diverse group of chemical compounds that bind to microtubules and affect their properties and function. Disruption of microtubules induces various cellular responses often leading to cell cycle arrest or cell death, the most common effect of MTAs. MTAs have found a plethora of practical applications in weed control, as fungicides and antiparasitics, and particularly in cancer treatment. Here we summarize the current knowledge of MTAs, the mechanisms of action and their role in cancer treatment. We further outline the potential use of MTAs in anti-metastatic therapy based on inhibition of cancer cell migration and invasiveness. The two main problems associated with cancer therapy by MTAs are high systemic toxicity and development of resistance. Toxic side effects of MTAs can be, at least partly, eliminated by conjugation of the drugs with various carriers. Moreover, some of the novel MTAs overcome the resistance mediated by both multidrug resistance transporters as well as overexpression of specific β-tubulin types. In anti-metastatic therapy, MTAs should be combined with other drugs to target all modes of cancer cell invasion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zheng, X., Wang, C., Xing, Y., Chen, S., Meng, T., You, H., Ojima, I., & Dong, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3871 · Cited by 24
RetractedMicrotubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson
Löwe, J., Li, H., Downing, K. H., & Nogales, E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5077 · Cited by 1,145
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Disrupting tumour blood vessels
Tozer, G. M., Kanthou, C., & Baguley, B. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1628 · Cited by 930
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832
Schöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., Grignani, G., Camargo, V., Bauer, S., Rha, S. Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01283-0 · Cited by 778
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
Bellmunt, J., Théodore, C., Demkov, T., Komyakov, B., Sengelov, L., Daugaard, G., Caty, A., Carles, J., Jagiello-Gruszfeld, A., Karyakin, O., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5534 · Cited by 766
Structural basis for the regulation of tubulin by vinblastine
Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005) · Nature · doi:10.1038/nature03566 · Cited by 734
Alushin, G. M., Lander, G. C., Kellogg, E. H., Zhang, R., Baker, D., & Nogales, E. (2014) · Cell · doi:10.1016/j.cell.2014.03.053 · Cited by 696
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Feldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R., Mullendore, M., Karikari, C., Alvarez, H., Iacobuzio-Donahue, C., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 694
Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase
Ezratty, E. J., Partridge, M. A., & Gundersen, G. G. (2005) · Nature Cell Biology · doi:10.1038/ncb1262 · Cited by 650
Siemann, D. W. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.05.001 · Cited by 611
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Ann Jordan, M., Thrower, D., & Wilson, L. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.3.401 · Cited by 531
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Drugs that target dynamic microtubules: A new molecular perspective
Stanton, R. A., Gernert, K. M., Nettles, J. H., & Aneja, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20242 · Cited by 526
Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia
Schoumacher, M., Goldman, R. D., Louvard, D., & Vignjevic, D. M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200909113 · Cited by 507
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
Karagiannis, G. S., Pastoriza, J. M., Wang, Y., Harney, A. S., Entenberg, D., Pignatelli, J., Sharma, V. P., Xue, E. A., Cheng, E., D’Alfonso, T. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0026 · Cited by 497
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
Prota, A. E., Bargsten, K., Zurwerra, D., Field, J. J., Díaz, J. F., Altmann, K.-H., & Steinmetz, M. O. (2013) · Science · doi:10.1126/science.1230582 · Cited by 489
Pereira, E. R., Kedrin, D., Seano, G., Gautier, O., Meijer, E. F. J., Jones, D., Chin, S.-M., Kitahara, S., Bouta, E. M., Chang, J., et al. (2018) · Science · doi:10.1126/science.aal3622 · Cited by 477
Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
Alam, A., Kowal, J., Broude, E., Roninson, I., & Locher, K. P. (2019) · Science · doi:10.1126/science.aav7102 · Cited by 469
Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P., & Ruiz i Altaba, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900039 · Cited by 463
Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton
Steinmetz, M. O., & Prota, A. E. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.001 · Cited by 461
Darshan, M. S., Loftus, M. S., Thadani-Mulero, M., Levy, B. P., Escuin, D., Zhou, X. K., Gjyrezi, A., Chanel-Vos, C., Shen, R., Tagawa, S. T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1417 · Cited by 432
The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography
Nettles, J. H., Li, H., Cornett, B., Krahn, J. M., Snyder, J. P., & Downing, K. H. (2004) · Science · doi:10.1126/science.1099190 · Cited by 421
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
Brown, M., Assen, F. P., Leithner, A., Abe, J., Schachner, H., Asfour, G., Bago-Horvath, Z., Stein, J. V., Uhrin, P., Sixt, M., et al. (2018) · Science · doi:10.1126/science.aal3662 · Cited by 417
Zasadil, L. M., Andersen, K. A., Yeum, D., Rocque, G. B., Wilke, L. G., Tevaarwerk, A. J., Raines, R. T., Burkard, M. E., & Weaver, B. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007965 · Cited by 402
The folate receptor as a rational therapeutic target for personalized cancer treatment
Assaraf, Y. G., Leamon, C. P., & Reddy, J. A. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.10.002 · Cited by 398
Structure of tubulin at 6.5 Å and location of the taxol-binding site
Nogales, E., Grayer Wolf, S., Khan, I. A., Ludueña, R. F., & Downing, K. H. (1995) · Nature · doi:10.1038/375424a0 · Cited by 389
The proliferation rate paradox in antimitotic chemotherapy
Mitchison, T. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-04-0335 · Cited by 363
Degrading Devices: Invadosomes in Proteolytic Cell Invasion
Linder, S., Wiesner, C., & Himmel, M. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154216 · Cited by 363
Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., Petruželka, L., Kumar, S., Sanz-Moreno, V., & Brábek, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.008 · Cited by 351
Self-citationA framework for the development of effective anti-metastatic agents
Anderson, R. L., Balasas, T., Callaghan, J., Coombes, R. C., Evans, J., Hall, J. A., Kinrade, S., Jones, D., Jones, P. S., Jones, R., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0134-8 · Cited by 341
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Martino, E., Casamassima, G., Castiglione, S., Cellupica, E., Pantalone, S., Papagni, F., Rui, M., Siciliano, A. M., & Collina, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.044 · Cited by 337
The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells
Paňková, K., Rösel, D., Novotný, M., & Brábek, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0132-1 · Cited by 333
Self-citationEarly Detection of Cancer: Past, Present, and Future
Schiffman, J. D., Fisher, P. G., & Gibbs, P. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.57 · Cited by 327
Mitosis is not a key target of microtubule agents in patient tumors
Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 314
Vascular‐targeting therapies for treatment of malignant disease
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2004) · Cancer · doi:10.1002/cncr.20299 · Cited by 310
Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy
Pak, E., & Segal, R. A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.07.026 · Cited by 301
Labi, V, & Erlacher, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.20 · Cited by 295
Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel
Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W.-K., Peters, L. J., & Milas, L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.18.1308 · Cited by 286
Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells
Morse, D. L., Gray, H., Payne, C. M., & Gillies, R. J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0130 · Cited by 283
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
Prota, A. E., Bargsten, K., Diaz, J. F., Marsh, M., Cuevas, C., Liniger, M., Neuhaus, C., Andreu, J. M., Altmann, K.-H., & Steinmetz, M. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408124111 · Cited by 279
Funahashi, Y., Okamoto, K., Adachi, Y., Semba, T., Uesugi, M., Ozawa, Y., Tohyama, O., Uehara, T., Kimura, T., Watanabe, H., et al. (2014) · Cancer Science · doi:10.1111/cas.12488 · Cited by 277
Kamath, K., Wilson, L., Cabral, F., & Jordan, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414477200 · Cited by 247
Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Shi, J., Orth, J. D., & Mitchison, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6699 · Cited by 234
Lopus, M., Oroudjev, E., Wilson, L., Wilhelm, S., Widdison, W., Chari, R., & Jordan, M. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0644 · Cited by 232
Wang, Y., Zhang, H., Gigant, B., Yu, Y., Wu, Y., Chen, X., Lai, Q., Yang, Z., Chen, Q., & Yang, J. (2016) · The FEBS Journal · doi:10.1111/febs.13555 · Cited by 225
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
Antonarakis, E., & Paller (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s13029 · Cited by 225
Rugo, H. S., Barry, W. T., Moreno-Aspitia, A., Lyss, A. P., Cirrincione, C., Leung, E., Mayer, E. L., Naughton, M., Toppmeyer, D., Carey, L. A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5298 · Cited by 222
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents
Fojo, T., & Menefee, M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm172 · Cited by 217
Microtubule dynamics: taking aim at a moving target
Wilson, L., & Jordan, M. A. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90119-1 · Cited by 215
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Kanthou, C., & Tozer, G. M. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00651.x · Cited by 197
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
Prota, A. E., Bargsten, K., Northcote, P. T., Marsh, M., Altmann, K., Miller, J. H., Díaz, J. F., & Steinmetz, M. O. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307749 · Cited by 195
Localization of an Exchangeable GTP BZinding Site at the Plus End of Microtubules
Mitchison, T. J. (1993) · Science · doi:10.1126/science.8102497 · Cited by 194
Ajabnoor, G. M. A., Crook, T., & Coley, H. M. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.139 · Cited by 189
Poruchynsky, M. S., Komlodi-Pasztor, E., Trostel, S., Wilkerson, J., Regairaz, M., Pommier, Y., Zhang, X., Kumar Maity, T., Robey, R., Burotto, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416418112 · Cited by 182
Mooney, C. J., Nagaiah, G., Fu, P., Wasman, J. K., Cooney, M. M., Savvides, P. S., Bokar, J. A., Dowlati, A., Wang, D., Agarwala, S. S., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0321 · Cited by 180
Yang, H., Ganguly, A., & Cabral, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160820 · Cited by 178
von Haefen, C., Wieder, T., Essmann, F., Schulze-Osthoff, K., Dörken, B., & Daniel, P. T. (2003) · Oncogene · doi:10.1038/sj.onc.1206280 · Cited by 177
Yoshino, T., Shiina, H., Urakami, S., Kikuno, N., Yoneda, T., Shigeno, K., & Igawa, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0147 · Cited by 176
Hari, M., Loganzo, F., Annable, T., Tan, X., Musto, S., Morilla, D. B., Nettles, J. H., Snyder, J. P., & Greenberger, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0190 · Cited by 175
Modes of invasion during tumour dissemination
Pandya, P., Orgaz, J. L., & Sanz‐Moreno, V. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12019 · Cited by 174
Yang, H. H., & Lin, P. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.001 · Cited by 174
Chang, Y. S., Jalgaonkar, S. P., Middleton, J. D., & Hai, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700455114 · Cited by 171
Vinca alkaloids: Anti-vascular effects in a murine tumour
Hill, S. A., Lonergan, S. J., Denekamp, J., & Chaplin, D. J. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90082-q · Cited by 168
An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
Parker, A. L., Teo, W. S., McCarroll, J. A., & Kavallaris, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071434 · Cited by 166
Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
Ferlini, C., Cicchillitti, L., Raspaglio, G., Bartollino, S., Cimitan, S., Bertucci, C., Mozzetti, S., Gallo, D., Persico, M., Fattorusso, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0540 · Cited by 165
Ojima, I., Slater, J. C., Michaud, E., Kuduk, S. D., Bounaud, P.-Y., Vrignaud, P., Bissery, M.-C., Veith, J. M., Pera, P., & Bernacki, R. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9604080 · Cited by 165
Findeisen, P., Mühlhausen, S., Dempewolf, S., Hertzog, J., Zietlow, A., Carlomagno, T., & Kollmar, M. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu187 · Cited by 165
The Mode of Action of Taxol: Apoptosis at Low Concentration and Necrosis at High Concentration
Yeung, T. K., Germond, C., Chen, X., & Wang, Z. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1375 · Cited by 160
Orth, J. D., Köhler, R. H., Foijer, F., Sorger, P. K., Weissleder, R., & Mitchison, T. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0412 · Cited by 159
Martello, L. A., Verdier‐Pinard, P., Shen, H. J., He, L., Torres, K. E., Orr, G. A., & Horwitz, S. B. (2003) · PubMed · Cited by 158
Spagnuolo, P. A., Hu, J., Hurren, R., Wang, X., Gronda, M., Sukhai, M. A., Meo, A. D., Boss, J., Ashali, I., Zavareh, R. B., et al. (2010) · Blood · doi:10.1182/blood-2009-09-243055 · Cited by 155
Chang, P., & Stearns, T. (1999) · Nature Cell Biology · doi:10.1038/71350 · Cited by 153
LI, R., Moudgil, T. L., Ross, H. J., & Hu, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401554 · Cited by 147
Tangutur, A. D., Kumar, D., Krishna, K. V., & Kantevari, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170104145640 · Cited by 140
Membrane Flow Drives an Adhesion-Independent Amoeboid Cell Migration Mode
O’Neill, P., Castillo‐Badillo, J. A., Meshik, X., Kalyanaraman, V., Melgarejo, K., & Gautam, N. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.029 · Cited by 140
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
Riggi, N., Aguet, M., & Stamenkovic, I. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044127 · Cited by 135
Mediavilla-Varela, M., Pacheco, F. J., Almaguel, F. A., Perez, J., Sahakian, E., Daniels‐Wells, T. R., Leoh, L. S., Padilla, A., Wall, N. R., Lilly, M. B., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-68 · Cited by 132
Potential anticancer role of colchicine-based derivatives: an overview
Kumar, A., Sharma, P. R., & Mondhe, D. M. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000464 · Cited by 132
Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities
Rohena, C. C., & Mooberry, S. L. (2014) · Natural Product Reports · doi:10.1039/c3np70092e · Cited by 131
Fanale, D., Bronte, G., Passiglia, F., Calò, V., Castiglia, M., Piazza, F. D., Barraco, N., Cangemi, A. G., Catarella, M. T., Insalaco, L., et al. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/690916 · Cited by 130
Caspase-2 is required for cell death induced by cytoskeletal disruption
Ho, L. H., Read, S. H., Dorstyn, L., Lambrusco, L., & Kumar, S. (2008) · Oncogene · doi:10.1038/sj.onc.1211005 · Cited by 126
Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
Yang, J., Wang, Y., Wang, T., Jiang, J. D., Botting, C. H., Liu, H., Chen, Q., Yang, J., Naismith, J. H., Zhu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms12103 · Cited by 124
Microtubules in 3D cell motility
Bouchet, B. P., & Akhmanova, A. S. (2017) · Journal of Cell Science · doi:10.1242/jcs.189431 · Cited by 123
Bijman, M. N. A., Amerongen, G. P. V. N., Laurens, N., van Hinsbergh, V. W. M., & Boven, E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0242 · Cited by 122
Němcová‐Fürstová, V., Kopperová, D., Balušíková, K., Ehrlichová, M., Brynychová, V., Václavíková, R., Daniel, P., Souček, P., & Kovár̆, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.020 · Cited by 121
Dabydeen, D. A., Burnett, J. C., Bai, R., Verdier‐Pinard, P., Hickford, S. J. H., Pettit, G. R., Blunt, J. W., Munro, M. H. G., Gussio, R., & Hamel, E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026641 · Cited by 119
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent.
Micheletti, G., Poli, M., Borsotti, P., Martinelli, M., Imberti, B., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 117
Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to Paclitaxel
Sharifi, S., Barar, J., Hejazi, M. S., & Samadi, N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8617 · Cited by 117
Veldhoen, R. A., Banman, S. L., Hemmerling, D., Odsen, R., Simmen, T., Simmonds, A. J., Underhill, D. A., & Goping, I. S. (2012) · Oncogene · doi:10.1038/onc.2012.92 · Cited by 114
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
Prota, A. E., Bargsten, K., Northcote, P. T., Marsh, M., Altmann, K., Miller, J. H., Díaz, J. F., & Steinmetz, M. O. (2014) · Angewandte Chemie · doi:10.1002/ange.201307749 · Cited by 113
Potential for improvement of docetaxel-based chemotherapy: a pharmacological review
Engels, F. K., Sparreboom, A., Mathôt, R. A. A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602698 · Cited by 111
Twelves, C., Cortés, J., Vahdat, L. T., Wanders, J., Akerele, C., & Kaufman, P. A. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.023 · Cited by 108
A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy
Yurkovetskiy, A., Yin, M., Bodyak, N. D., Stevenson, C. A., Thomas, J. D., Hammond, C. E., Qin, L., Zhu, B., Gumerov, D. R., Ter‐Ovanesyan, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0129 · Cited by 108
Singer, S., Malz, M., Herpel, E., Warth, A., Bissinger, M., Keith, M., Muley, T., Meister, M. A., Hoffmann, H., Penzel, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3338 · Cited by 103
Grisham, R. N., Ky, B., Tewari, K. S., Chaplin, D. J., & Walker, J. L. (2018) · Gynecologic Oncology Research and Practice · doi:10.1186/s40661-017-0058-5 · Cited by 103
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
Larsen, A. R., Bai, R.-Y., Chung, J., Borodovsky, A., Rudin, C. M., Riggins, G. J., & Bunz, F. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0755-t · Cited by 101
Mechanisms of Resistance to Cabazitaxel
Durán, G. E., Wang, Y. C., Francisco, E. B., Rose, J. C., Martinez, F. J., Coller, J., Brassard, D., Vrignaud, P., & Sikic, B. I. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0155 · Cited by 100
Plasticity of Cancer Cell Invasion—Mechanisms and Implications for Therapy
Boekhorst, V. T., & Friedl, P. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.07.005 · Cited by 100
Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma
Kim, T. J., Ravoori, M. K., Landen, C. N., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4018 · Cited by 98
Prota, A. E., Setter, J. R., Waight, A. B., Bargsten, K., Murga, J., Díaz, J. F., & Steinmetz, M. O. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.023 · Cited by 91
Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2
Mhaidat, N. M., Wang, Y., Avery‐Kiejda, K. A., Zhang, X. D., & Hersey, P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0564 · Cited by 90
Janssen, K., Pohlmann, S., Jänicke, R. U., Schulze‐Osthoff, K., & Fischer, U. (2007) · Blood · doi:10.1182/blood-2007-02-073213 · Cited by 89
The structure of invadopodia in a complex 3D environment
Tolde, O., Rösel, D., Veselý, P., Folk, P., & Brábek, J. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.04.003 · Cited by 89
Self-citationInterplay Between Spindle Architecture and Function
Helmke, K. J., Heald, R., & Wilbur, J. D. (2013) · International review of cytology · doi:10.1016/b978-0-12-407694-5.00003-1 · Cited by 88
Luo, Y., Ling, Y., Guo, W., Pang, J., Liu, W., Fang, Y., Wen, X., Wei, K., & Gao, X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.108 · Cited by 85
Field, J. J., Pera, B., Calvo, E., Canales, Á., Zurwerra, D., Trigili, C., Rodríguez‐Salarichs, J., Matesanz, R., Kanakkanthara, A., Wakefield, S. J., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.05.008 · Cited by 85
Fehm, T. N., Müller, V., Alix‐Panabières, C., & Pantel, K. (2008) · Breast Cancer Research · doi:10.1186/bcr1869 · Cited by 83
Microtubules as antiparasitic drug targets
Fennell, B., Naughton, J. A., Barlow, J. W., Brennan, G. P., Fairweather, I., Hoey, E. M., McFerran, N. V., Trudgett, A., & Bell, A. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.5.501 · Cited by 83
Taxanes in combined modality therapy for solid tumors
Choy, H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00112-8 · Cited by 82
Tumour targeting by microtubule-depolymerising vascular disrupting agents
Kanthou, C., & Tozer, G. M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1443 · Cited by 81
Bouchet, B. P., Noordstra, I., van Amersfoort, M., Katrukha, E. A., Ammon, Y.-C., ter Hoeve, N. D., Hodgson, L., Dogterom, M., Derksen, P. W. B., & Akhmanova, A. S. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.11.009 · Cited by 81
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
Shi, J., & Mitchison, T. J. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0003 · Cited by 79
McMeekin, S., Dizon, D. S., BARTER, J. F., Scambia, G., Manzyuk, L., Lisyanskaya, A. S., Oaknin, A., Ringuette, S., Mukhopadhyay, P., Rosenberg, J., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.04.026 · Cited by 79
Freedman, H., Huzil, J. T., Luchko, T., Ludueña, R. F., & Tuszyński, J. A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8003336 · Cited by 75
The role of Tau protein in resistance to paclitaxel
Smoter, M., Bodnar, L., Duchnowska, R., Stec, R., Grala, B., & Szczylik, C. A. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1696-7 · Cited by 74
Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers
Person, F., Wilczak, W., Hube‐Magg, C., Burdelski, C. M., Möller‐Koop, C., Simon, R., Noriega, M., Sauter, G., Steurer, S. A., Burdak‐Rothkamm, S., et al. (2017) · Tumor Biology · doi:10.1177/1010428317712166 · Cited by 74
Liu, J., Towle, M. J., Cheng, H., Saxton, P. L., Reardon, C., Wu, J., Murphy, E. A., Kuznetsov, G., Johannes, C. W., Tremblay, M. R., et al. (2007) · PubMed · Cited by 72
Kumar, B., Kumar, R., Skvortsova, I., & Kumar, V. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666160928110818 · Cited by 72
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
Adams, S., Yang, H. C., Savariar, E. N., Aguilera, J. A., Crisp, J. L., Jones, K. A., Whitney, M. A., Lippman, S. M., Cohen, E. E. W., Tsien, R. Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms13019 · Cited by 72
Johnson, T. A., Tenney, K., Cichewicz, R. H., Morinaka, B. I., White, K. N., Amagata, T., Subramanian, B., Media, J. E., Mooberry, S. L., Valeriote, F. A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070410z · Cited by 70
Pinto, L. C., Soares, B. M., Pinheiro, J. D. J. V., Riggins, G. J., de Assumpção, P. P., Burbano, R. M. R., & Montenegro, R. C. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.08.007 · Cited by 69
Armas‐López, L., Zúñiga, J., Arrieta, O. G., & Ávila‐Moreno, F. (2017) · Oncotarget · doi:10.18632/oncotarget.19527 · Cited by 69
Recent Advances in Vascular Disrupting Agents in Cancer Therapy
Porcù, E., Bortolozzi, R., Basso, G., & Viola, G. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.104 · Cited by 68
Kantarjian, H. M., Lioure, B., Kim, S. K., Atallah, E. L., Leguay, T., Kelly, K., Marolleau, J., Escoffre‐Barbe, M., Thomas, X., Cortes, J. E., et al. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.12.004 · Cited by 68
Géraud, A., Xu, H. P., Beuzeboc, P., & Kirova, Y. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2265-z · Cited by 68
The role of individual caspases in cell death induction by taxanes in breast cancer cells
Jelínek, M., Balušíková, K., Schmiedlová, M., Němcová‐Fürstová, V., Šrámek, J., Stančíková, J., Zanardi, I., Ojima, I., & Kovár̆, J. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0155-7 · Cited by 67
Self-citationGridelli, C., Rossi, A., Maione, P., Rossi, E., Castaldo, V., Sacco, P. C., & Colantuoni, G. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0287 · Cited by 65
Kerbel, R. S., & Shaked, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.005 · Cited by 65
Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine
Castle, B., McCubbin, S., Prahl, L. S., Bernens, J. N., Sept, D., & Odde, D. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-08-0567 · Cited by 65
Epothilones: From Discovery to Clinical Trials
Forli, S. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666141130095855 · Cited by 62
Garon, E. B., Neidhart, J. D., Gabrail, N. Y., de Oliveira, M. R., Balkissoon, J., & Kabbinavar, F. F. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s109186 · Cited by 58
Pagano, A., Honoré, S., Mohan, R., Bergès, R., Akhmanova, A. S., & Braguer, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.05.010 · Cited by 56
Microtubules as antifungal and antiparasitic drug targets
Chatterji, B. P., Jindal, B., Srivastava, S., & Panda, D. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.545349 · Cited by 55
Sun, R., Liu, Z., Wang, L., Wei-dong, L., Liu, J., Ding, C., Yuan, Y., Lei, G., & Xu, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3361-y · Cited by 54
Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
Miller, A. V., Hicks, M. A., Nakajima, W., Richardson, A. C., Windle, J. J., & Harada, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060685 · Cited by 53
Flores, M. L., Castilla, C., Ávila, R., Ruíz‐Borrego, M., Sáez, C., & Japón, M. Á. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1864-9 · Cited by 48
Salinas, R., Ogohara, C., Thomas, M. I., Shukla, K. P., Miller, S. I., & Ko, D. C. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-06-0294 · Cited by 48
Cabazitaxel-induced autophagy via the PI3K/Akt/mTOR pathway contributes to A549 cell death
Huo, R., Wang, L., Liu, P., Zhao, Y., Zhang, C., Bai, B., Liu, X., Shi, C., Wei, S., & Zhang, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5648 · Cited by 48
Savry, A., Carre, M., Bergès, R., Rovini, A. M. F., Pobel, I., Chacon, C., Braguer, D., & Bourgarel‐Rey, V. (2013) · Neoplasia · doi:10.1593/neo.121074 · Cited by 46
ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines
Oba, T., Izumi, H., & Ito, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11727 · Cited by 46
Aldonza, M. B. D., Hong, J., Alinsug, M. V., Song, J., & Lee, S. K. (2016) · Oncotarget · doi:10.18632/oncotarget.9118 · Cited by 45
Organization of Non-centrosomal Microtubules in Epithelial Cells
Toya, M., & Takeichi, M. (2016) · Cell Structure and Function · doi:10.1247/csf.16015 · Cited by 45
Hansen, S., Westergaard, D., Thomsen, M. B. H., Vistesen, M. V., Nguyen, K., Fogh, L., Belling, K., Wang, J., Yang, H., Gupta, R., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3072-4 · Cited by 44
Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling
Kosla, J., Paňková, D., Plachý, J., Tolde, O., Bicanová, K., Dvořák, M., Rösel, D., & Brábek, J. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-51 · Cited by 44
Self-citationShin, D., Kim, S. N., Chae, J., Hyun, S., Seo, S., Lee, Y., Lee, K., Kim, S., Lee, Y., Jeong, J. M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.039 · Cited by 44
Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs
Smith, J. A., Slusher, B. S., Wozniak, K. M., Farah, M. H., Smiyun, G., Wilson, L., Feinstein, S. C., & Jordan, M. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3116 · Cited by 44
Suppression of angiogenesis and tumour progression by combretastatin and derivatives
Sherbet, G. V. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.032 · Cited by 41
Ghasemi, F., Black, M., Vizeacoumar, F., Pinto, N., Ruicci, K. M., Le, C. C. S. H., Lowerison, M. R., Leong, H. S., Yoo, J., Fung, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17292 · Cited by 38
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
Matesanz, R., Trigili, C., Rodríguez‐Salarichs, J., Zanardi, I., Pera, B., Nogales, A., Fang, W., Jiménez‐Barbero, J., Canales, Á., Barasoaı́n, I., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.048 · Cited by 36
Caspase-2 is involved in cell death induction by taxanes in breast cancer cells
Jelínek, M., Balušíková, K., Kopperová, D., Němcová‐Fürstová, V., Šrámek, J., Fidlerová, J., Zanardi, I., Ojima, I., & Kovár̆, J. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-42 · Cited by 36
Self-citationThe BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism
Craik, A. C., Veldhoen, R. A., Czernick, M., Buckland, T. W., Kyselytzia, K., Ghosh, S., Lai, R. L., Damaraju, S., Underhill, D. A., Mackey, J. R., et al. (2010) · Oncogene · doi:10.1038/onc.2010.272 · Cited by 35
EB1 and cytoplasmic dynein mediate protrusion dynamics for efficient 3‐dimensional cell migration
Jayatilaka, H., Giri, A., Karl, M. N., Aifuwa, I., Trenton, N. J., Phillip, J. M., Khatau, S. B., & Wirtz, D. (2017) · The FASEB Journal · doi:10.1096/fj.201700444rr · Cited by 34
Field, J., Northcote, P. T., Paterson, I., Altmann, K., Díaz, J. F., & Miller, J. H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050971 · Cited by 29
Melanoma cell sensitivity to Docetaxel‐induced apoptosis is determined by class III β‐tubulin levels
Mhaidat, N. M., Thorne, R. F., de Bock, C. E., Zhang, X. D., & Hersey, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.12.014 · Cited by 27
Novel oral taxane therapies: recent Phase I results
Flores, J. P., & Saif, M. W. (2013) · Clinical Investigation · doi:10.4155/cli.13.18 · Cited by 26
Meyer, C. J., Krauth, M., Wick, M. J., Shay, J. W., Gellert, G. C., Brabander, J. K. D., Northcote, P. T., & Miller, J. H. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0167 · Cited by 26
Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
Wang, L., Jin, J. Q., Zhou, Y., Tian, Z., Jablons, D. M., & He, B. (2017) · Oncotarget · doi:10.18632/oncotarget.22856 · Cited by 25
Field, J. J., Pera, B., Estévez‐Gallego, J., Calvo, E., Rodríguez‐Salarichs, J., Sáez-Calvo, G., Zuwerra, D., Jordi, M., Andreu, J. M., Prota, A. E., et al. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00704 · Cited by 24
Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.007 · Cited by 23
Microtubule dynamics regulation contributes to endothelial morphogenesis
Lyle, K. S., Corleto, J. A., & Wittmann, T. (2012) · BioArchitecture · doi:10.4161/bioa.22335 · Cited by 23
Docetaxel combined with targeted therapies in metastatic breast cancer
Cortés, J., & Roche, H. H. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.08.001 · Cited by 23
Élez, E., Gomez‐Roca, C., Matos-Pita, A. S., Argilés, G., Valentin, T., Coronado, C., Iglesias, J. L., Macarulla, T. M., Bétrian, S., Fudio, S., et al. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0674-x · Cited by 22
Robert, F., Harper, K., Ackerman, J., & Gupta, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1026-5 · Cited by 14
Jelínek, M., Balušíková, K., Daniel, P., Němcová‐Fürstová, V., Kirubakaran, P., Jaček, M., Wei, L., Wang, X., Vondrášek, J., Ojima, I., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.04.002 · Cited by 14
Self-citationDrugs for solid cancer the productivity crisis prompts a rethink
Brábek, J., Rösel, Veselý, P., & Fernandes, M. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s45177 · Cited by 13
Self-citationA role for microtubules in endothelial cell protrusion in three‐dimensional matrices
Martins, G. G., & Kolega, J. J. (2012) · Biology of the Cell · doi:10.1111/boc.201100088 · Cited by 12
Khatra, H., Khan, P. P., Pattanayak, S., Bhadra, J., Rather, B., Chakrabarti, S., Saha, T., & Sinha, S. (2018) · ChemBioChem · doi:10.1002/cbic.201700631 · Cited by 10
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance
Ogden, A., Rida, P. C. G., Reid, M. D., Küçük, Ö., & Aneja, R. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1016425 · Cited by 9
Cited by
Therapeutic strategies to overcome taxane resistance in cancer
Das, T., Anand, U., Pandey, S. K., Ashby, C. R., Assaraf, Y. G., Chen, Z.-S., & Dey, A. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100754 · Cited by 253
Metadata
- Authors
- Čermák, V., Dostál, V., Jelínek, M., Libusová, L., Kovář, J., Rösel, D., & Brábek, J.
- Venue
- European Journal of Cell Biology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 99
- Issue
- 4
- Pages
- 151075
- ISSN
- 0171-9335 (ISSN-L)
- OpenAlex
- W3020969291
- Cited by
- 275
- References
- 179
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.